Business Wire

LYCRA ® VintageFX Fiber Officially Launches at Kingpins Amsterdam

14.4.2026 09:00:00 CEST | Business Wire | Press Release

Share

The LYCRA Company, a global leader in fiber and technology solutions for the apparel industry, today announced the global launch ofLYCRA® VintageFX fiber at Kingpins Amsterdam, April 15-16. This next-generation fiber delivers the authentic look of vintage denim in modern silhouettes while providing the comfort, fit and shape retention that consumers expect from stretch denim.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260414923000/en/

LYCRA® VintageFX fiber officially launches at Kingpins Amsterdam, April 15–16. The LYCRA Company’s latest innovation delivers the authentic look of heritage denim in modern silhouettes while providing the comfort, fit, and shape retention that consumers expect from stretch denim.

Designed for denim and woven fabrics, LYCRA® VintageFX fiber sets a new performance benchmark, enabling brands and mills to recreate rigid, heritage-inspired looks without sacrificing recovery, durability, or wearer comfort. This innovation responds to the industry’s shift toward away-from-the-body silhouettes and looser fits—including wide-leg, flares, boyfriend, and mom jeans—where maintaining fit and stability remains a challenge, particularly in the waist, hips and crotch.

“After previewing LYCRA® VintageFX fiber at Kingpins Amsterdam last year, we’re excited to officially introduce it to the global denim community,” said Ebru Ozaydin, product category director – denim and ready-to-wear at The LYCRA Company. “For brands and garment makers, its dual-core yarn construction, low growth, and high recovery open new design possibilities. These features enable compact, less bulky fabrics with an authentic vintage appearance, but without the instability of traditional low-stretch constructions.”

A New Standard in Comfort Stretch Denim

Engineered with a proprietary and patent-pending fabric application, LYCRA® VintageFX fiber works in tandem with LYCRA® fiber in a dual-core structure. During finishing, this fiber shrinks under heat, controlling elastic extension, protecting the fiber core, and delivering enhanced shape retention to reduce bagging and sagging. Additional technical benefits include:

  • Low growth and good recovery, even after industrial wash and bleach processes
  • Compact fabric construction for better drape and less bulk
  • Authentic vintage denim aesthetics with soft compression and a gentle-to-the-skin feel
  • Reduced seam slippage for improved garment quality and longer wear life

The result is a fabric solution that supports modern comfort stretch denim, balancing heritage-inspired looks with the needs of contemporary lifestyles. Apparel made with this fiberalsoqualifies for LYCRA XTRA LIFE® fiber branding at the point of sale, reinforcing garment durability.

Value for Brands and Retailers

“LYCRA® VintageFX fiber enables brands and retailers to deliver a strong consumer value proposition, filling a critical market gap while elevating collections,” said Arnaud Ruffin, vice president, brands and retail at The LYCRA Company. “This product shows how our commitment to textile innovation supports the value chain with unique, performance-driven solutions.”

LYCRA® VintageFX fiber has passed The LYCRA Company’s rigorous testing protocols, ensuring consistent performance, durability, and quality. Brands and mills can also access co-creation opportunities at LYCRA® Labs, where they can tap into deep technical expertise and collaborative innovation to bring distinctive stretch solutions to market.

Show visitorscan also experience sample fabrics and garments made with Renewable LYCRA® fiber, which is made from 70 percent plant-based resources. This spandex supports efforts to reduce the environmental impact of apparel, offering a more sustainable option for denim. LYCRA® ADAPTIV fiber, which offers a second-skin fit and enables size-inclusive denim, will also be on display.

Kingpins’ guests are invited to visit The LYCRA Company’s representatives at stand B10 at the SugarFactory in Amsterdam. To schedule a meeting at the show or learn more about LYCRA® VintageFX fiber, visit this website.

About The LYCRA Company

The LYCRA Company innovates and produces fiber and technology solutions for the apparel and personal care industries, and owns the leading consumer brands: LYCRA®, LYCRA HyFit®, LYCRA® T400®, COOLMAX®, THERMOLITE®, ELASPAN®, SUPPLEX® and TACTEL®. Headquartered in Wilmington, Delaware, U.S., The LYCRA Company is recognized worldwide for its sustainable products, technical expertise, and marketing support. The LYCRA Company focuses on adding value to its customers’ products by developing unique innovations designed to meet the consumer’s need for comfort and lasting performance. Learn more at thelycracompany.com.

LYCRA® is a trademark of The LYCRA Company.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260414923000/en/

Contacts

Izaskun Hernanz
Izaskun.Hernanz@lycra.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press Release

Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP alone as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. The oral presentation of these data is taking place at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting being held May 29 – June 2, 2026, in Chicago (Abstract #LBA7000. Session: Oral Abstract Session – Hematologic Malignancies – Lymphoma and Chronic Lymphocytic Leukemia. May 30, 4:00 – 7:00 p.m. ET [3:00 – 6:00 p.m.

Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press Release

The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a

SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press Release

Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press Release

NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press Release

Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye